(Q28256565)

English

Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90)

scientific article

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90) (English)

0 references

author name string

P Rolan

series ordinal

1

0 references

language of work or name

English

0 references

publication date

October 1997

0 references

published in

Cephalalgia

0 references

volume

17 Suppl 18

0 references

page(s)

21-7

0 references

cites work

Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F0333102497017S1804

retrieved

21 January 2018

The clinical pharmacokinetics of zolmitriptan.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F0333102497017S1804

retrieved

21 January 2018

311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F0333102497017S1804

retrieved

21 January 2018

Diagnosis and management of migraine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F0333102497017S1804

retrieved

21 January 2018

Pharmacological Modification of Gastric Emptying: Effects of Propantheline and Metoclopromide on Paracetamol Absorption

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F0333102497017S1804

retrieved

21 January 2018

The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F0333102497017S1804

retrieved

21 January 2018

Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F0333102497017S1804

retrieved

21 January 2018

Clinical pharmacokinetics of fluoxetine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F0333102497017S1804

retrieved

21 January 2018

Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F0333102497017S1804

retrieved

21 January 2018

Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F0333102497017S1804

retrieved

21 January 2018

The clinical profile of sumatriptan: safety and tolerability

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F0333102497017S1804

retrieved

21 January 2018

Identifiers

DOI

10.1177/0333102497017S1804

0 references

PubMed publication ID

9399014

0 references

(Q28256565)

Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)